Eliminating need to dilate

Article

Faster technology to be able to screen for diabetic retinopathy is a requirement as the disease is becoming more prevalent.

Faster technology to be able to screen for diabetic retinopathy is a requirement as the disease is becoming more prevalent. A new retinal imaging system has been confirmed to match or outperform fundus cameras in a recent clinical trial.

The DRIVE trial looked at 100 people with diabetes and examined the efficacy of the EasyScan (i-Optics). The performance of the system was assessed head-to-head with a fundus camera in the early diagnosis of diabetic retinopathy.

It was shown that the non-mydriatic confocal SLO technology successfully scanned all 100 patients without pharmacological dilation. Additionally, a large portion of the study group could be imaged in under 3 minutes. The results of this trial will be featured in ARVO and will add to the results of an earlier trial of the system’s imaging performance.

One of the first doctors to use the system in the US Dr Steven Squillace gave his opinion on the system. "I've worked with SLO technology for retinal evaluation over 10 years ago as part of a group practice. We saw the benefit of undilated fundus images, but also the drawback… When I heard there was a smaller version being launched, I thought it could be what I needed."

Dr Squillace has used the technology on over 100 patients and now states that he uses it exclusively for routine check ups.

If you would like to read more about the EasyScan the full article can be found in the May print issue of OTEurope.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
Related Content
© 2025 MJH Life Sciences

All rights reserved.